Overweight and obesity. Overweight and obesity
Conditions
Interventions
Intervention 1: Intervention group 1: Training with spirulina: Spirulina group will take two 500 mg spirulina capsules daily (morning and evening) for eight weeks. Rayhaneh Pharmaceutical Company of
Sponsors
Zahedan University of Medical Sciences
Eligibility
Sex/Gender
Male
Age
30 Years to 50 Years
Inclusion criteria
Inclusion criteria: Aged between 50-30 years old General physical and mental health Body mass index (BMI) more than 25 kg / m 2
Exclusion criteria
Exclusion criteria: If the participant has exercised regularly during 6 months before the start of training sessions If the participant has suffers from cardiovascular diseases If the participant has suffers from diabetes disease If the participant has suffers from hormonal disorders disease If the participant has suffers from kidney disease If the participant has suffers from liver disease If the participant is a smoker If the participant has recently had any surgery or medical interventions
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Asprosin. Timepoint: Before the intervention and two months after the intervention. Method of measurement: Plasma Asprosin levels were measured using an ELISA kit (Zell Bio Co made in Germany with a sensitivity of 0.05 ng/m), and ELISA-by-ELISA Reader (US lotion model).;Glucose. Timepoint: Before the intervention and two months after the intervention. Method of measurement: ParsAzmon Kit (mg/dl).;Triglyceride. Timepoint: Before the intervention and two months after the intervention. Method of measurement: ParsAzmon Kit (mg/dl).;Cholesterol. Timepoint: Before the intervention and two months after the intervention. Method of measurement: ParsAzmon Kit (mg/dl).;High Density Lipoprotein. Timepoint: Before the intervention and two months after the intervention. Method of measurement: ParsAzmon Kit (mg/dl).;Low Density Lipoprotein. Timepoint: Before the intervention and two months after the intervention. Method of measurement: ParsAzmon Kit (mg/dl). | — |
Secondary
| Measure | Time frame |
|---|---|
| Least body mass. Timepoint: Before the intervention and two months after the intervention. Method of measurement: Body composition analyzer, model IOI 353, made by Jawon Medical, South Korea.;Lean body mass. Timepoint: Before the intervention and two months after the intervention. Method of measurement: Body composition analyzer, model IOI 353, made by Jawon Medical, South Korea.;Waist to height ratio. Timepoint: Before the intervention and two months after the intervention. Method of measurement: Height will be measured with Sahand Company's height meter and Waist circumference will be measured with a Tape meter (made in Iran). | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactHossein Nakhaei
Zahedan University of Medical Sciences
Outcome results
None listed